Cargando…
Mechanistic Evaluation of a Novel Small Molecule Targeting Mitochondria in Pancreatic Cancer Cells
BACKGROUND: Pancreatic cancer is one of the deadliest cancers with a 5-year survival rate of 6%. Therapeutic options are very limited and there is an unmet medical need for safe and efficacious treatments. Cancer cell metabolism and mitochondria provide unexplored targets for this disease. We recent...
Autores principales: | Shabaik, Yumna H., Millard, Melissa, Neamati, Nouri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549929/ https://www.ncbi.nlm.nih.gov/pubmed/23349858 http://dx.doi.org/10.1371/journal.pone.0054346 |
Ejemplares similares
-
Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity
por: Millard, Melissa, et al.
Publicado: (2010) -
Integrin Targeted Therapeutics
por: Millard, Melissa, et al.
Publicado: (2011) -
Small Molecule Inhibitors of CXCR4
por: Debnath, Bikash, et al.
Publicado: (2013) -
Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
por: Shetu, Shaila A., et al.
Publicado: (2023) -
Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin
por: Shi, Wei, et al.
Publicado: (2018)